ShuanzengWeiMD

Pathology • Philadelphia, PA

Cytopathology, Anatomic Pathology, Clinical Pathology

Associate Professor

Join to view full profile

Dr. Wei is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wei's full profile

Already have an account?

Office
333 Cottman Ave
Philadelphia, PA 19111
Phone+1 215-728-3675

Fax+1 215-214-3901

Education & Training

University of Pennsylvania Health SystemFellowship, Pathology-Anatomic and Clinical, 2015 - 2016
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical

Certifications & Licensure

PA State Medical License 2011 - 2024
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Cytopathology

Publications & Presentations

PubMed

G-Protein-Coupled Receptor-Associated Sorting Protein 1 Overexpression Is Involved in the Progression of Benign Prostatic Hyperplasia, Early-Stage Prostatic Malignant ...
Cesar Torres-Luna, Shuanzeng Wei, Sreenivas Bhattiprolu, George Tuszynski, Vicki L Rothman
Cancers. 2024-10-30
PHF1::TFE3-positive fibromyxoid sarcoma? Report of 2 cases and review of 13 cases of PHF1::TFE3-positive ossifying fibromyxoid tumor in the literature.
Shuanzeng Wei, Arthur S Patchefsky, Jianming Pei, Scot A Brown, Atrayee Basu Mallick
American Journal of Clinical Pathology. 2024-09-09
1 citations
Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells.
Yijun Yang, Silvia Anahi Valdés-Rives, Qing Liu, Tong Gao, Chakkapong Burudpakdee
Cancer Cell. 2024-08-12

Journal Articles

Intrathyroid Cystic Thyroglossal Duct Remnant and Ectopic Thymus: A Fortuitous or Development-Related Association?
Shuanzeng Wei, MD, Surgery Today

Press Mentions

Fox Chase Cancer Center Researchers Propose a New Type of Sarcoma, PHF1::TFE3-Positive Fibromyxoid SarcomaOctober 9th, 2024
Powerful Chromosome Analysis Allows for More Accurate Subtyping of Renal Cell CarcinomasJuly 26th, 2019